tradmap

TXG 10x Genomics, Inc.

$34.76 +8.24%

Healthcare · Laboratory Analytical Instruments

10x Genomics, Inc. (TXG) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $4.5 billion. Shares last traded at $34.76, near their 52-week high. Over the past year the stock is up 231.0%. Net profit margin is -6.8%, below the peer median of -1.5%. Revenue grew 5.2% year over year.

Market Cap
$4.5B
Shares Out
128.3M
EPS (TTM)
$-0.60
P/E Ratio
P/S Ratio
6.94
P/B Ratio
5.48
Dividend / Share
Dividend Yield
52-Week High
$35.64
52-Week Low
$10.40
Volume
209,050
Avg Vol (3m)
167,760.238

Performance

1W
+19.66%
1M
+55.94%
3M
+89.27%
6M
+121.40%
YTD
+109.33%
1Y
+231.05%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
70.19
SMA (50)
$25.33
SMA (200)
$19.11
Price vs SMA50
+37.21%
Price vs SMA200
+81.85%
ATR (14)
$2.17

Financials

Revenue
$643M
Net Income
$-44M
Gross Margin
69.1%
Operating Margin
-9.5%
Net Margin
-6.8%
Return on Equity
-5.3%
Return on Assets
-4.3%
Current Ratio
5.90
Debt / Equity
0.00
Revenue Growth (YoY)
+5.2%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $-0.10 2026-05-08
FY 2025 $-0.35 2026-02-13
Q3 2025 $-0.22 2025-11-07
Q2 2025 $0.00 2025-08-08
Q1 2026 $-0.28 2026-05-08
FY 2025 $-1.52 2026-02-13

Full earnings history →

Laboratory Analytical Instruments peers

TXG vs 14 industry peers (Laboratory Analytical Instruments), by market cap.

P/S vs peers
6.94 / 2.95 med
+135% premium
Net margin vs peers
-6.8% / -1.5% med
below median
1–14 of 14
AAgilent Technologies$35.9B27.555.1718.8%+2.23%
WATWaters Corporation$34.9B54.3211.0320.3%-0.44%
ILMNIllumina, Inc.$24.5B28.805.6419.6%+1.68%
MTDMettler Toledo$23.1B26.595.7421.6%+1.22%
RVTYRevvity$11.1B46.223.908.4%+2.23%
BRKRBruker Corp$8.7B-1049.062.53-0.2%+4.51%
BIOBio-Rad Laboratories, Inc.$7.6B10.022.9529.4%-0.80%
AVTRAvantor, Inc.$6.5B-12.321.00-8.1%+1.16%
TXG10x Genomics, Inc.$4.5B-102.516.94-6.8%+8.24%
ALMRAlamar Biosciences, Inc.$1.5B+8.56%
EYPTEyepoint, Inc.$1.1B-4.91+3.35%
CTKBCytek Biosciences, Inc.$488M-7.342.42-33.0%-4.91%
PACBPacific Biosciences Of California, Inc.$432M-0.79+3.35%
LABSTANDARD BIOTOOLS INC.$324M-4.323.79-87.8%+2.65%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.